Clinical Trial

NeuroCytotron in the Treatment of Autism Spectrum Disorder

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2025 (before its estimated March 6, 2025 completion). Its status may not reflect the trial's current state.
Summary
Preliminary Efficacy and Feasibility of Using NeuroCytotron in the Treatment of Autism Spectrum Disorder
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-26; most recent amendment 2025-02-04.
Trial Details
NCT Number NCT06477263
Lead Sponsor Neurocytonix, Inc.
Conditions Autism Spectrum Disorder
Enrollment 100 participants
Start Date 2024-07-15
Primary Completion 2025-03-06 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-06